Skip to content
Search
Search
Quick Exit
About
About Inquiries
About the Lampard Inquiry
Scope of the Lampard Inquiry
Final Terms of Reference
Explanatory Note on Scope
List of Issues
Inquiry Team
Terminology and Glossary
Financial Report
FAQs
General FAQs
Terms of Reference FAQs
Hearings FAQS
Evidence FAQS
Core Participant and Witness FAQs
Policies and Protocols
Protocol on Core Participants
Hearings Protocols
Protocol for the April Hearing
Protocol on the Questioning of Witnesses in Oral Hearings under Rule 10 of the Inquiry Rules 2006
Witnesses Protocols
Compelling Witnesses
Protocol on Witness Statements
Protocol on Vulnerable Witnesses
Protocol on Whistleblowing
Anonymity and Restriction Orders
Patient Identity Restriction Orders
Patient Anonymity
Restriction Orders
Protocol on Restriction Orders
Costs protocols
Protocol on Legal Costs
Protocol on Witness Expenses
Protocol on Applications for
Core Participant Legal Funding
Notice of Determination
Information Handling
Statement of approach: Redaction, Data Protection and Privacy
Protocol on Documents
Privacy Information Notice
Prohibition on the destruction
of documents
Lampard Inquiry Disclosure Update – March 2025
Appropriate Policy Document
Protocol on the Role and Appointment of Assessors
Protocol on the Role and Instruction of Experts
Protocol on Equality, Diversity
and Inclusion
Lived Experience Framework
Protocol on Rule 13 Warning Letters and the Opportunity to Respond Process [‘OTR’]
Statement of Approach
Statement of Approach – Investigating illustrative cases
Statement of Approach to Investigating Sexual Safety
Hearings
Hearings
Logistical Information
Hearings FAQS
Statement of Approach – Investigating Illustrative Cases
Evidence and Reports
Evidence Overview
Opening Statements
Hearing Evidence Bundles
Bereaved Families & Friends – Evidence
Background Presentations to Inquiry Hearings
Paper on Public Inquiry Recommendations
Evidence FAQS
Participants and Witnesses
Core Participants
Statement of Approach
How to Apply
List of Core Participants
Compelling Witnesses
Core Participant and Witness FAQs
Bereaved Families and Friends FAQs
Open Letter from Chair to bereaved families (April 2026)
Staff Witnesses FAQs
Support
Emotional support provided by the Inquiry
Support Services
Safeguarding
Contact
Updates
About
About Inquiries
About the Lampard Inquiry
Scope of the Lampard Inquiry
Final Terms of Reference
Explanatory Note on Scope
List of Issues
Inquiry Team
Terminology and Glossary
Financial Report
FAQs
General FAQs
Terms of Reference FAQs
Hearings FAQS
Evidence FAQS
Core Participant and Witness FAQs
Policies and Protocols
Protocol on Core Participants
Hearings Protocols
Protocol for the April Hearing
Protocol on the Questioning of Witnesses in Oral Hearings under Rule 10 of the Inquiry Rules 2006
Witnesses Protocols
Compelling Witnesses
Protocol on Witness Statements
Protocol on Vulnerable Witnesses
Protocol on Whistleblowing
Anonymity and Restriction Orders
Patient Identity Restriction Orders
Patient Anonymity
Restriction Orders
Protocol on Restriction Orders
Costs protocols
Protocol on Legal Costs
Protocol on Witness Expenses
Protocol on Applications for
Core Participant Legal Funding
Notice of Determination
Information Handling
Statement of approach: Redaction, Data Protection and Privacy
Protocol on Documents
Privacy Information Notice
Prohibition on the destruction
of documents
Lampard Inquiry Disclosure Update – March 2025
Appropriate Policy Document
Protocol on the Role and Appointment of Assessors
Protocol on the Role and Instruction of Experts
Protocol on Equality, Diversity
and Inclusion
Lived Experience Framework
Protocol on Rule 13 Warning Letters and the Opportunity to Respond Process [‘OTR’]
Statement of Approach
Statement of Approach – Investigating illustrative cases
Statement of Approach to Investigating Sexual Safety
Hearings
Hearings
Logistical Information
Hearings FAQS
Statement of Approach – Investigating Illustrative Cases
Evidence and Reports
Evidence Overview
Opening Statements
Hearing Evidence Bundles
Bereaved Families & Friends – Evidence
Background Presentations to Inquiry Hearings
Paper on Public Inquiry Recommendations
Evidence FAQS
Participants and Witnesses
Core Participants
Statement of Approach
How to Apply
List of Core Participants
Compelling Witnesses
Core Participant and Witness FAQs
Bereaved Families and Friends FAQs
Open Letter from Chair to bereaved families (April 2026)
Staff Witnesses FAQs
Support
Emotional support provided by the Inquiry
Support Services
Safeguarding
Contact
Updates
Quick Exit
Home
Evidence
Hearing Day 57 Evidence
Hearing Day 57 Evidence
Evidence Information
Submission date:
5th Oct 2026
Hearing:
Hearing Day 57 – October Hearing (2026)
Submission date:
5th Oct 2026
Available Documents (48)
Filter evidence
ELT028530_Deteriorating Patient Physical Health Policy v1
(PDF: 41.1 MB)
ELT025529_RB-3 Resuscitation Policy version 13.0
(PDF: 62.84 MB)
ELT028132_First Witness Statement of Rebecca Lingard
(PDF: 13.47 MB)
ELT025509_Witness statement of Ruth Bradley
(PDF: 4.6 MB)
NHSE024200_GH038 NHS England Principles for using digital technologies in mental health inpatient
(PDF: 13.58 MB)
NHSE028961_PS027 Attachment 2 NHSE Email re Oxevision concerns
(PDF: 5.74 MB)
NHSE029019_Email from NHSE to CQC re Review of NHS Trusts Use of Oxevision
(PDF: 1.81 MB)
NHSE029018_Attachment 1 NHSE029019 Trust use of VBMS - verified by Regions
(PDF: 10.44 MB)
NHSE029017_Attachment 2 NHSE029019 A review of NHS Trust policies SOP for the use of Oxevision
(PDF: 2.66 MB)
NHSE028973_PS021 NHSE internal email re status update on Oxevision
(PDF: 2.51 MB)
NHSE028972_PS029 Email chain between NHSE and MHRA re Oxevision
(PDF: 2.22 MB)
NHSE028965_PS013 Oxehealth response to MHRA Questions
(PDF: 8.31 MB)
NHSE028962_PS005 Emails chain between NHSE and MHRA re Oxevision concerns
(PDF: 7.79 MB)
NHSE028959_PS027 NHSE emails re Oxevision concerns
(PDF: 911.96 KB)
NHSE028956_PS010 Email from MHRA to NHSE
(PDF: 1.92 MB)
NHSE028949_PS002 Tracking log entry extract_NHSE Patient Safety team
(XLSX: 23.79 KB)
NHSE028945_PS017 Email chain between NHSE and MHRA
(PDF: 5.09 MB)
NHSE028942_PS024 NHSE patient safety meeting VRM update
(PDF: 3.39 MB)
NHSE028940_PS020 Email between NHSE and MHRA
(PDF: 1005.83 KB)
NHSE028936_PS012 Email from MHRA to NHSE re questions for Oxehealth
(PDF: 3.03 MB)
NHSE028929_PS001 NHSE internal email re request to consider Oxevision at NHSE internal meeting
(PDF: 2.31 MB)
NHSE028922_Email chain with MH DoN_s Forum
(PDF: 4.52 MB)
NHSE028913_NRLS analysis summary Oxehealthoxevision
(PDF: 15.26 MB)
NHSE028114_Second Witness Statement of Gareth Harry on behalf of NHSE
(PDF: 12.71 MB)
NHSE028059_GH069 Transcript of feedback session on principles for the procurement and use of dig
(PDF: 54.82 MB)
NHSE027849_GH055 DHSC and NHSE System-wide Digital Safety Review Group DSRG Terms of Reference
(PDF: 5.96 MB)
NHSE027840_GH052 NHSE email-chain re follow-up on the use of vision-based monitoring systems
(PDF: 5.82 MB)
NHSE024239_GH002 Clinical Risk Management its application in the Manufacture of Health IT System
(PDF: 94.16 MB)
NHSE024238_GH001 Digital clinical safety assurance
(PDF: 6.88 MB)
NHSE024237_GH003 Clinical Risk Management it_s Application in the Deployment and Use of Health I
(PDF: 95.83 MB)
NHSE024231_GH009 Economic Impact Case Study Oxevision
(PDF: 8.43 MB)
NHSE024230_GH013 Email re Oxehealth Guardian Article
(PDF: 3.85 MB)
NHSE024228_GH010 Health Technology Pathway Navigation Tool for Innovators in England
(PDF: 53.21 MB)
NHSE024226_GH014 Email re Digital mental health technology
(PDF: 3.09 MB)
NHSE024225_GH015 Email re Feedback on concerns about Oxevision
(PDF: 4.69 MB)
NHSE024224_GH016 National recommendations guidance and best practice on safe use of VBPMS
(PDF: 45.5 MB)
NHSE024223_GH017 Open letter on the use of Oxevision in inpatient settings
(PDF: 4.96 MB)
NHSE024222_GH018 Email re Stop Oxevision campaign
(PDF: 4.42 MB)
NHSE024220_GH019 Empty words false promises and window-dressing An overview NHS Englands new Dig
(PDF: 12.46 MB)
NHSE024210_GH023 Final Ombudsman Report _Miss B 1
(PDF: 19.88 MB)
NHSE024209_GH031 Good practice principles in vision based patient monitoring technology V4 LDu c
(PDF: 3.13 MB)
NHSE024204_GH033 The use and impact of surveillance-based technology initiatives in inpatient an
(PDF: 67.3 MB)
NHSE024203_GH034 Use of Vision Based Monitoring Systems in Mental Health Inpatient Services FINA
(PDF: 3.69 MB)
NHSE023333_First Witness Statement of Gareth Harry_ on behalf of NHSE
(PDF: 4.33 MB)
INQY028221_Expert Report of Dr Chess Denman
(PDF: 28.44 MB)
INQY025968_Expert Health Statistician Report on Oxevision Evidential Baseand Case Study Methodologies
(PDF: 9.22 MB)
EPUT023595_Witness Statement of Dr Kallur Suresh and Zephan Trent
(PDF: 132.35 MB)
EPUT009026_Second Witness statement of Zephan Trent re Oxevision - R9 3c
(PDF: 3.18 MB)
Related hearings
Hearing Day 57 – October Hearing (2026)
Hearing type:
Public Hearing
5th Oct 2026
View Hearing
Other Evidence
Hearing Day 54 – Evidence
Hearing Day 58 Evidence
Evidence Information
Hearing:
Hearing Day 57 – October Hearing (2026)
search evidence
Search evidence
View advanced filters
Evidence submission dates
2026 (select all)
View by month
Oct 2026 (select all)
View by day
15 Oct 2026
14 Oct 2026
13 Oct 2026
12 Oct 2026
08 Oct 2026
07 Oct 2026
06 Oct 2026
05 Oct 2026
Jul 2026 (select all)
View by day
21 Jul 2026
09 Jul 2026
08 Jul 2026
07 Jul 2026
06 Jul 2026
Feb 2026 (select all)
View by day
16 Feb 2026
11 Feb 2026
10 Feb 2026
09 Feb 2026
04 Feb 2026
03 Feb 2026
02 Feb 2026
2025 (select all)
View by month
Dec 2025 (select all)
View by day
08 Dec 2025
Oct 2025 (select all)
View by day
27 Oct 2025
23 Oct 2025
22 Oct 2025
21 Oct 2025
20 Oct 2025
16 Oct 2025
15 Oct 2025
14 Oct 2025
13 Oct 2025
Jul 2025 (select all)
View by day
14 Jul 2025
10 Jul 2025
09 Jul 2025
08 Jul 2025
07 Jul 2025
May 2025 (select all)
View by day
15 May 2025
13 May 2025
12 May 2025
08 May 2025
06 May 2025
01 May 2025
Apr 2025 (select all)
View by day
30 Apr 2025
29 Apr 2025
28 Apr 2025
1999 (select all)
View by month
Dec 1999 (select all)
View by day
30 Nov 1999
Quick Exit
About
About Inquiries
About the Lampard Inquiry
Scope of the Lampard Inquiry
Final Terms of Reference
Explanatory Note on Scope
List of Issues
Inquiry Team
Terminology and Glossary
Financial Report
FAQs
General FAQs
Terms of Reference FAQs
Hearings FAQS
Evidence FAQS
Core Participant and Witness FAQs
Policies and Protocols
Protocol on Core Participants
Hearings Protocols
Protocol for the April Hearing
Protocol on the Questioning of Witnesses in Oral Hearings under Rule 10 of the Inquiry Rules 2006
Witnesses Protocols
Compelling Witnesses
Protocol on Witness Statements
Protocol on Vulnerable Witnesses
Protocol on Whistleblowing
Anonymity and Restriction Orders
Patient Identity Restriction Orders
Patient Anonymity
Restriction Orders
Protocol on Restriction Orders
Costs protocols
Protocol on Legal Costs
Protocol on Witness Expenses
Protocol on Applications for
Core Participant Legal Funding
Notice of Determination
Information Handling
Statement of approach: Redaction, Data Protection and Privacy
Protocol on Documents
Privacy Information Notice
Prohibition on the destruction
of documents
Lampard Inquiry Disclosure Update – March 2025
Appropriate Policy Document
Protocol on the Role and Appointment of Assessors
Protocol on the Role and Instruction of Experts
Protocol on Equality, Diversity
and Inclusion
Lived Experience Framework
Protocol on Rule 13 Warning Letters and the Opportunity to Respond Process [‘OTR’]
Statement of Approach
Statement of Approach – Investigating illustrative cases
Statement of Approach to Investigating Sexual Safety
Hearings
Hearings
Logistical Information
Hearings FAQS
Statement of Approach – Investigating Illustrative Cases
Evidence and Reports
Evidence Overview
Opening Statements
Hearing Evidence Bundles
Bereaved Families & Friends – Evidence
Background Presentations to Inquiry Hearings
Paper on Public Inquiry Recommendations
Evidence FAQS
Participants and Witnesses
Core Participants
Statement of Approach
How to Apply
List of Core Participants
Compelling Witnesses
Core Participant and Witness FAQs
Bereaved Families and Friends FAQs
Open Letter from Chair to bereaved families (April 2026)
Staff Witnesses FAQs
Support
Emotional support provided by the Inquiry
Support Services
Safeguarding
Contact
Updates